TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
GEBE Medicinsk och Bioteknisk Konsult AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
369
|
326
|
217 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-61
|
1,841
|
-33 |
| EBITDA |
-69
|
1,783
|
-14 |
| Total assets |
3,465
|
3,921
|
2,060 |
| Current assets |
3,465
|
3,921
|
488 |
| Current liabilities |
374
|
375
|
28 |
| Equity capital |
3,025
|
3,486
|
1,987 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
87.3%
|
88.9%
|
96.5% |
| Turnover per employee |
184
|
163
|
108 |
| Profit as a percentage of turnover |
-16.5%
|
564.7%
|
-15.2% |
| Return on assets (ROA) |
-1.8%
|
47.0%
|
-1.6% |
| Current ratio |
926.5%
|
1045.6%
|
1742.9% |
| Return on equity (ROE) |
-2.0%
|
52.8%
|
-1.7% |
| Change turnover |
43
|
109
|
151 |
| Change turnover % |
13%
|
50%
|
229% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.